All articles by GlobalData Healthcare

ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity

At the American College of Cardiology’s 74th Annual Scientific Session in Chicago, further results and analyses were presented from the…
CNS market resurgence: a decade-long slump ends with $80bn milestone

In 2025, the central nervous system (CNS) market is forecast to surpass $80bn in sales for the first time since…
Large pharma drug licensing from China hits high at 28% in 2024

Licensing agreements for Chinese drug candidates have surged, with large pharma in-licensing 28% of innovator drugs from Chinese biopharma companies…
ACC 2025: Imbria’s ninerafaxstat data shows potential for cardiometabolic HFpEF

On 29 March, Dr. Sarah Birkhoelzer, presented results from the open-label, Phase IIa trial of ninerafaxstat during a moderated poster…
Biopharma IPOs showed signs of recovery in 2024

Biopharmaceutical initial public offerings (IPOs) saw an upturn in 2024, with 50 completed IPOs raising a total of $8.52 billion…

ACC 25: Oral semaglutide reduces cardiovascular events in T2D patients

At the American College of Cardiology’s 74th Annual Scientific Session, held from 29 March to 31 March 2025 in Chicago,…
AGA overhauls UC treatment pathway: early, high-efficacy therapies now preferred

In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the pharmacological management of moderate-to-severe ulcerative…
Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

The pharma industry has been left reeling by the recent news of US government trade tariffs, with companies Eli Lilly…
Blood cancers dominate CAR-T pipeline

Chimeric antigen receptor T-cell (CAR-T) therapeutics have emerged as a dominant cancer treatment within cell and gene therapies (CGT). The…
IA-2A positivity identified as a key predictor in type 1 diabetes progression

A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant marker for disease…